Previous 10 | Next 10 |
State of Michigan to provide funding towards the treatment of substance use and opioid use disorders with prescription digital therapeutics (PDTs), giving Michiganders access to Pear’s reSET® and reSET-O® Pear Therapeutics, Inc. (Nasdaq: PEAR), the leade...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced management will participate in the 9th Annual BTIG MedTech, Digital Health, Life Science & Diagnostics C...
Pear Therapeutics, Inc. (Nasdaq: PEAR) , the parent company of Pear Therapeutics (US), Inc., the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), announced today a value-based agreement with Oklahoma Health Care Autho...
2021 commercial operational performance metrics, including number of prescriptions, prescription fulfillment rate, and number of covered lives met public guidance 2021 financial results to be announced in March 2022 operational and financial metrics remain unchanged ...
Pear Therapeutics, Inc. (Nasdaq: PEAR), the parent company of Pear Therapeutics (US), Inc., the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs) , today announced an agreement with Point32Health , a leading he...
Shares of Pear Therapeutics Inc (NASDAQ: PEAR) closed up nearly 25% on Monday after BTIG said the Boston-headquartered company was the best positioned in the prescription digital therapeutics (PDT) space. BTIG’s Marie Thibault sees a 60% upside On Monday, analyst Marie Th...
Medallion Financial (NASDAQ:MFIN) represented one of the standout decliners in Wednesday's midday trading. A regulatory action caused the stock to lose more than a quarter of its value. Alibaba (NYSE:BABA) also came under selling pressure in intraday action. The stock lost ground on news that...
Gainers: BiondVax (NASDAQ:BVXV) +96%. SeaChange (NASDAQ:SEAC) +46%. Acasti (NASDAQ:ACST) +43%. Society Pass (NASDAQ:SOPA) +30%. ALJ Regional Holdings (NASDAQ:ALJJ) +26%. Red Cat (OTCQB:RCAT) +23%. Getnet Adquirencia (NASDAQ:GET) +23%. Lottery (NASDAQ:LTRY) +20%. Bellerophon Therapeutics (NASD...
Pear Therapeutics (NASDAQ:PEAR) acquired and/or licensed two new digital therapeutic assets, from Waypoint Health Innovations and a researcher named Fredrik Holländare of Örebro University, that are designed for the treatment of a spectrum of depression conditions. Compan...
Pear Therapeutics announces the acquisition and license of two digital therapeutic assets designed to treat patients with a range of depression symptoms Pear is developing a prescription digital therapeutic (PDT) candidate that may be developed for use alone or in combin...